How have ANHGY shares performed in 2024?

Mediclinic International's stock was trading at $5.49 at the beginning of the year. Since then, ANHGY shares have increased by 0.0% and is now trading at $5.49. View the best growth stocks for 2024 here .

How do I buy shares of Mediclinic International?

Shares of ANHGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTC:ANHGY

Mediclinic International (ANHGY) Stock Price, News & Analysis

→ It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad)

Free ANHGY Stock Alerts

$5.49

0.00 (0.00%)

(As of 05/12/2023)

Compare

Today's Range: $5.49
▼
$5.49
50-Day Range: $5.49
▼
$5.49
52-Week Range: $5.49
▼
$5.58

Volume: N/A
Average Volume: 100 shs
Market Capitalization: N/A

P/E Ratio: 7.95
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Dividend

Get Mediclinic International alerts:

Ad Insiders Exposed

The Hard Truth About Investing For Retirement

Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.

Click To Access This Powerful Training Right Now!

About Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

ANHGY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ANHGY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ANHGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTC
Sector: Medical
Industry: Medical Care Facilities
Sub-Industry: N/A
Current Symbol: OTC:ANHGY
CUSIP: N/A
CIK: N/A
Web: www.mediclinic.com
Phone: 27 21 809 6500
Fax: N/A
Employees: 33,683
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 7.95
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Dr. Carel Aron van der Merwe D.A. (SA) (Age 60)
F.C.A. (SA), M.B.Ch.B., Group CEO & Exec. Director
Comp: $1.74M
Mr. Petrus Jurgens Myburgh (Age 48)
Group CFO & Exec. Director
Comp: $1.17M
Mr. Koert H. S. Pretorius B.Compt (Age 60)
MBL, Group Chief Operating Officer
Dr. Dirk C. Le Roux (Age 63)
Group Chief Information Officer
Mr. James Arnold
Head of Investor Relations
Mr. Gert C. Hattingh B.Acc. (Hons) (Age 58)
CA(SA), Group Chief Governance Officer
Mr. Biren Valodia
Chief Marketing Officer of Medi-Clinic Southern Africa
Ms. Clara Findlay
Chief Legal Officer of Medicalinic Southern Africa
Mr. Wimpie Aucamp
Chief Operating Officer of Medi-Clinic for Southern Africa
Dr. Daniel Liedtke (Age 53)
Chief Exec. Officer of Hirslanden

Key Competitors

View All Competitors

ANHGY Stock Analysis - Frequently Asked Questions

How have ANHGY shares performed in 2024?: Mediclinic International's stock was trading at $5.49 at the beginning of the year. Since then, ANHGY shares have increased by 0.0% and is now trading at $5.49.
View the best growth stocks for 2024 here.
How do I buy shares of Mediclinic International?: Shares of ANHGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTC:ANHGY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial